ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,026, issued on June 24, was assigned to Gliknik Inc. (Baltimore).
"Methods of treating inflammatory disorders with multivalent Fc compounds" was invented by David S. Block (Baltimore) and Henrik Olsen (Baltimore).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for the identification of patients with an inflammatory or autoimmune disease that demonstrate an inadequate response to treatment with a multi-Fc therapeutic, and the determination of an optimal dose of a multi-Fc therapeutic for said patient based on the patient's circulating levels of inactivated C3b (iC3b) and/or additional complement components that ma...